Clene, Inc. (CLNN)
4.435
+0.12
(+2.66%)
USD |
NASDAQ |
Aug 24, 16:00
4.435
0.00 (0.00%)
After-Hours: 20:00
Clene Shareholders Equity (Quarterly) : -24.78M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -24.78M |
| March 31, 2026 | -18.81M |
| December 31, 2025 | -17.59M |
| September 30, 2025 | -12.36M |
| June 30, 2025 | -8.55M |
| March 31, 2025 | -4.973M |
| December 31, 2024 | -8.857M |
| September 30, 2024 | -4.125M |
| June 30, 2024 | -0.504M |
| March 31, 2024 | 4.264M |
| December 31, 2023 | 13.39M |
| September 30, 2023 | 21.41M |
| June 30, 2023 | 21.53M |
| March 31, 2023 | -1.627M |
| December 31, 2022 | 3.237M |
| September 30, 2022 | -9.319M |
| June 30, 2022 | -0.563M |
| Date | Value |
|---|---|
| March 31, 2022 | 2.017M |
| December 31, 2021 | 12.60M |
| September 30, 2021 | 5.686M |
| June 30, 2021 | -25.92M |
| March 31, 2021 | -36.08M |
| December 31, 2020 | 0.341M |
| September 30, 2020 | 5.00M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 5.00M |
| September 30, 2019 | 5.00M |
| June 30, 2019 | 5.00M |
| March 31, 2019 | 5.00M |
| December 31, 2018 | 5.00M |
| September 30, 2018 | 4.585M |
| June 30, 2018 | -0.0312M |
| March 31, 2018 | -0.0156M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| NovelStem International Corp. | -2.032M |
| Brainstorm Cell Therapeutics, Inc. | -11.60M |
| Summit Therapeutics, Inc. | 629.98M |
| Kezar Life Sciences, Inc. | 65.24M |
| Protara Therapeutics, Inc. | 161.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.04M |
| Total Liabilities (Quarterly) | 47.82M |
| Debt to Equity Ratio | -0.9018 |
| Current Ratio | 3.074 |
| Net Debt Paydown Yield | -0.36% |